Innoviva (INVA) Capital Expenditures Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 315.19% |
| Sep 30, 2024 | 3.85% |
| Sep 30, 2023 | 687.88% |
| Mar 31, 2023 | 266.67% |
| Dec 31, 2016 | 2,700.00% |
| Dec 31, 2015 | -99.25% |
| Mar 31, 2015 | -99.63% |
| Dec 31, 2014 | -87.54% |
| Jun 30, 2014 | -253.98% |
| Mar 31, 2014 | 118.92% |
| Dec 31, 2013 | 308.81% |
| Sep 30, 2013 | -58.38% |
| Jun 30, 2013 | 4.86% |
| Mar 31, 2013 | -32.91% |
| Dec 31, 2012 | -71.16% |
| Sep 30, 2012 | 1,517.50% |
| Jun 30, 2012 | -52.32% |
| Mar 31, 2012 | -20.13% |
| Dec 31, 2011 | 57.39% |
| Sep 30, 2011 | -126.14% |